Entry Point Capital, LLC Moderna, Inc. Transaction History
Entry Point Capital, LLC
- $188 Million
- Q2 2025
A detailed history of Entry Point Capital, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 7,972 shares of MRNA stock, worth $204,561. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,972
Previous 8,279
3.71%
Holding current value
$204,561
Previous $234,000
6.41%
% of portfolio
0.12%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
860Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$656 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$567 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$443 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$228 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...